Skip to content
  • About Us
  • Science
  • Pipeline
  • News
  • Careers
  • Contact Us
  • Video Overview
Menu
  • About Us
  • Science
  • Pipeline
  • News
  • Careers
  • Contact Us
  • Video Overview

Category: Press Release

Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases

Funds will advance Ray Therapeutics’ optogenetics gene therapy programs for blinding retinal diseases.

Ray Therapeutics closes $6M seed financing to advance novel optogenetics platform to treat blinding diseases

Top-tier advanced therapies investor 4BIO Capital led the financing round.

The financing will be used to advance its lead optogenetics gene therapy Ray-001 into clinical trials for retinitis pigmentosa.

©Ray Therapeutics. All rights reserved | Site by BKW